Kamalpreet Arora

Kamalpreet Arora is an experienced regulatory professional currently serving as Senior Director of Regulatory CMC at enGene since January 2025. Previously, Kamalpreet held the position of Director of Regulatory Affairs CMC at Viridian Therapeutics, Inc. from December 2022 to January 2025, focusing on compliance with FDA regulations for biotherapeutics and developing regulatory strategies. Prior experience includes serving as Associate Director of Regulatory Affairs Biopharm Global at Sandoz, where responsibilities included regulatory advice and CMC development, as well as a Senior Consultant CMC at Biologics Consulting, where Kamalpreet developed CMC strategies and conducted gap analyses for various regulatory submissions. Early in the career, Kamalpreet worked as a Regulatory Affairs and CMC Consultant at FDAInsight, LLC, contributing to the preparation of regulatory documents and gap analysis for biotherapeutics.